NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Active Not RecruitingPhase 3
Sponsor: Bristol-Myers Squibb
Conditions: Hepatocellular Carcinoma, Liver Cancer
Interventions: Nivolumab, Placebo
Countries: United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile
This study will investigate if nivolumab will improve recurrence-free survival (RFS) compared to placebo in participants with HCC who have undergone complete resection or have achieved a complete response after local ablation, and who are at high risk of recurrence
Eligibility overview
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * Participants with a first diagnosis of HCC who have undergone a curative resection or ablation * Participants are eligible to enroll if they have non-viral related-HCC, or if they have HBV-HCC, or HCV-HCC * Child-Pugh Score 5 or 6 * Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1 Exclusion Criteria: * Known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC * Any evidence of tumor metastasis or co-existing malignant disease * Participants previously receiving any prior therapy for HCC, including loco-regional therapies * Participants who have undergone a liver transplant or those who are in the waiting list for liver transplantation * Participants who have received a live/attenuated vaccine within 30 days of randomization (eg, varicella, zoster, yellow fever, rotavirus, oral polio and measles, mumps, rubella \[MMR\]). Other protocol defined inclusion/exclusion criteria apply
Locations (184)
- Anniston, Alabama, United States
- Phoenix, Arizona, United States
- Tucson, Arizona, United States
- Los Angeles, California, United States
- Palo Alto, California, United States
- San Francisco, California, United States
- Aurora, Colorado, United States
- Miami, Florida, United States
- Miami, Florida, United States
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- Westwood, Kansas, United States
- New Orleans, Louisiana, United States
- Ann Arbor, Michigan, United States
- Minneapolis, Minnesota, United States
- St Louis, Missouri, United States
- New York, New York, United States
- New York, New York, United States
- New York, New York, United States
- White Plains, New York, United States
- Cleveland, Ohio, United States
- Portland, Oregon, United States
- Austin, Texas, United States
- Dallas, Texas, United States
- Dallas, Texas, United States
- Tyler, Texas, United States
- Richmond, Virginia, United States
- Seattle, Washington, United States
- Gorriti, Buenos Aires, Argentina
- Pilar, Buenos Aires, Argentina
- + 154 more on CT.gov